Janssen gets FDA nod for type 2 diabetes drug

04/1/2013 | HealthDay News

The FDA has granted Janssen Pharmaceuticals approval for its type 2 diabetes drug Invokana. The drug, a sodium-glucose co-transporter 2 inhibitor, was the first of its class to gain federal approval.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC